Correlates of late HIV diagnosis: Implications for testing policy

International Journal of STD and AIDS

Volumn 18, Issue 5, 2007, Pages 312-317

  Delpierre, Cyrille ^a,c   Dray Spira, Rosemary ^a,b   Cuzin, Lise ^c   Marchou, Bruno ^c   Massip, Patrice ^c   Lang, Thierry ^a   Lert, F ^a   Sitta, R ^a   Obadia, Y ^a   Spire, B ^a   Peretti Wattel, P ^a   Bouhnik, A D ^a   Heard, I ^d   Pierret, J ^a   Schiltz, M A ^a   Fagnani, J ^e   Riandey, B ^f   Afsa, C ^f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c CHU PURPAN   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e CNRS   (France)

^f INSERM U379 ORS PACA ^*

Author keywords

France; Heterosexual longstanding couples; HIV infection; Late diagnosis; Migrants

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CORRELATION ANALYSIS; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; FEMALE; HEALTH CARE POLICY; HEALTH EDUCATION; HETEROSEXUAL MALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MARRIED MAN; PRIORITY JOURNAL; RISK FACTOR; SEXUALITY; FAMILY SIZE; FRANCE; HEALTH SURVEY; HIGH RISK BEHAVIOR; HOMOSEXUALITY; MIDDLE AGED; MIGRATION; PATIENT ATTITUDE; TIME;

ADULT; CD4 LYMPHOCYTE COUNT; FAMILY CHARACTERISTICS; FEMALE; FRANCE; HEALTH POLICY; HEALTH SURVEYS; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK-TAKING; SEXUAL PARTNERS; TIME FACTORS; TRANSIENTS AND MIGRANTS;

EID: 34447136802     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207780749709     Document Type: Article

References (22)

1. Palella F, Delaney K, Moorman A, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 1998;338:853-60
2. Palella F, Deloria-Knoll M, Chmiel J, Moorman A, Wood K, Greenberg A. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4 cell strata. Ann Intern Med 2003;138:620-6
3. Sabin C, Smith C, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004;18:2145-51
4. Girardi E, Aloisi M, Arici C, Pezzotti P, Serraino D, Bazano R. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J AIDS 2004;36:951-9
5. Hogg R, Yip B, Chan K. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286:2568-77
6. CDC. Late versus early testing of HIV -16 sites, United States, 2000-2003. Morb Mortal Wkly Rep 2003;52:581-6
7. Prevention CfDCa. Adoption of protective behaviors among persons with recent HIV infection and diagnosis: Alabama, New Jersey, and Tennessee, 1997-1998. MMWR 2000;49:512-15
8. Levi J. Ensuring timely access to care for people with HIV infection: a public health imperative. Am J Public Health 2002;92:339-40
9. Sullivan A, Curtis H, Sabin C, Johnson M. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005;330:1301-2
10. Hamers F, Downs A. The changing face of the HIV epidemic in western: what are the implications for public health policies? Lancet 2004;364:83-94
11. Castilla J, Sobrino P, De la Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002;27:1945-51
12. Wood E, Montaner J, Tyndall M, Schechter M, O'Shaughnessy M, Hogg R. Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. JID 2003;188:1164-70
13. Nadal J, Bourdillon F, Haury B, Antoine G. Les principales caractéristiques de la file active hospitalière des personnes atteintes d'infection à VIH en 1996. Bull Epidémiol Hebd 1997;23:107-8
14. Peretti-Watel P, Riandey B, Dray-Spira R, et al. Enquêter la population séropositive en France: l'enquête ANRS-EN12-VESPA. Population 2005;60:525-50
15. InVS. Premiers résultats du nouveau dispositif de surveillance de l'infection à VIH et situation du sida au 30 septembre 2003. BEH 2004;24-25:102-8
16. Dougan S, Gilbart T, Sinka K, Evans B. HIV infections acquired through heterosexual intercourse in the United Kingdom: findings from national surveillance. BMJ 2005;330:1303-4
17. Vernay-Vaisse C, Enel P, Bendiane M, Rey D, Carrieri M, Obadia Y. Facteurs associés à la découverte de la séropositivité au VIH à un stade d'immunodépression avancé. BEH 2002;15:61-3
18. Premiers résultats de l'Enquête Presse Gay 2004 [http://www.invs.sante.fr/display/?doc=presse/2005/communiques/epg_220605/index. html] (Accessed 22/06/2005)
19. Chadborn T, Baster K, Delpech V, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005;19:513-20
20. Longo B, Pezzotti P, Boros S, Urciuoli R, Rezza G. Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care 2005;17:834-41
21. Mortier E, Chan Chee C, Bloch M, et al. Nouveaux consultants pour une infection par le VIH dans un hôpital du nord des Hauts-de-Seine. BEH 2003;1:2-3
22. Gremy I, Beltzer N. HIV risk and condom use in the adult heterosexual population in France between 1992 and 2001: return to the starting point? AIDS 2004;18:805-9